Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $2.63 Million - $3.36 Million
12,825 Added 272.47%
17,532 $3.59 Million
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $819,297 - $1.06 Million
-3,831 Reduced 44.87%
4,707 $1.1 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $174,599 - $200,376
672 Added 8.54%
8,538 $2.25 Million
Q4 2021

Feb 09, 2022

SELL
$271.6 - $314.21 $1.4 Million - $1.62 Million
-5,150 Reduced 39.57%
7,866 $2.47 Million
Q3 2021

Nov 10, 2021

SELL
$274.82 - $308.34 $678,255 - $760,983
-2,468 Reduced 15.94%
13,016 $3.66 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $3.9 Million - $4.31 Million
15,484 New
15,484 $4.27 Million
Q1 2021

May 13, 2021

SELL
$204.88 - $255.03 $810,710 - $1.01 Million
-3,957 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $306,345 - $351,434
1,639 Added 70.71%
3,957 $805,000
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $387,175 - $466,613
2,318 New
2,318 $436,000
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $401,117 - $645,837
-3,540 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $1.01 Million - $1.88 Million
-9,636 Reduced 73.13%
3,540 $447,000
Q4 2019

Feb 12, 2020

BUY
$163.48 - $173.61 $40,379 - $42,881
247 Added 1.91%
13,176 $2.23 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $1.19 Million - $1.33 Million
7,441 Added 135.59%
12,929 $2.17 Million
Q2 2019

Aug 12, 2019

BUY
$144.16 - $172.9 $250,405 - $300,327
1,737 Added 46.31%
5,488 $949,000
Q1 2019

May 10, 2019

SELL
$123.7 - $156.3 $95,743 - $120,976
-774 Reduced 17.1%
3,751 $574,000
Q4 2018

Feb 11, 2019

BUY
$120.82 - $174.09 $546,710 - $787,757
4,525 New
4,525 $572,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.